Teduglutide

Gattex

GLP-2 Analog

NADAC/unit N/A

No Shortage Tier 1: 8.5% PA Req: 49.8%

GATTEX ® is indicated for the treatment of adults and pediatric patients 1 year of age and older with Short Bowel Syndrome (SBS) who are dependent on parenteral support .

Covered Lives

Generic Manufacturers

TAKEDA PHARMACEUTICALS USA INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Teduglutide drfinder.aiFind doctors who prescribe Teduglutide rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Teduglutide

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.